Stellar Pharmaceuticals Inc., a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, yesterday announced that Mr. Martin Thrasher has joined the company’s board as a new director.

A seasoned international executive, Mr. Thrasher has spent over three decades working around the globe for blue chip companies such as General Foods, McCormick & Co, Campbell Soup Co and ConAgra Foods Inc. He lived and worked in Canada, Australia, Belgium and the USA. Currently, Mr. Thrasher is President of FMT Consulting, a boutique advisory and consulting firm.

Arnold Tenney, Stellar’s Chairman of the Board, commented, “We are extremely pleased to have Martin join the board of Stellar. We believe his wealth of experience in running large, highly competitive global businesses is an excellent complement to the entrepreneurial spirit of Stellar. We look forward to his contributions as we continue to expand the business and strengthen shareholder value.”